menu search

Open society foundations announce 2023 soros justice fellows

New York, Nov. 03, 2023 (GLOBE NEWSWIRE) — The Open Society Foundations is pleased to announce the 2023 coho...

November 3, 2023, 8:52 pm

Sensei biotherapeutics reports favorable clinical data for sns-101 at 2023 sitc annual meeting

– Clinical dose escalation data for SNS-101 monotherapy show well tolerated safety profile, potentially best-in-class pharmacokinetics, and encourag...

November 3, 2023, 8:05 pm

Alternative protein global investment leader big idea ventures announces first new protein fund ii singapore cohort

SINGAPORE, Oct. 30, 2023 (GLOBE NEWSWIRE) — Big Idea Ventures, a global leader investing in alternative protein and food technology, announced its f...

October 31, 2023, 1:00 am

Lisata therapeutics announces first patient treated in the cholangiocarcinoma cohort of the bolster trial of lsta1, a novel tumor-targeting and penetrating peptide

Phase 2a double-blind, placebo-controlled, multi-center, randomized study evaluating LSTA1 in combination with standard-of-care versus standard-of-car...

October 24, 2023, 12:00 pm

Ambrx biopharma: potential with recently released prostate cancer data

Ambrx Biopharma Inc. updated data of ARX517 for the treatment of patients with mCRPC shows encouraging anti-tumor activity with ...

October 23, 2023, 6:50 pm

Harpoon therapeutics stock soars on ‘promising' lung cancer drug results

Harpoon Therapeutics Inc shares surged as much as 40% in pre-market trading on Monday after the clinical-stage immunotherapy company announced that it...

October 23, 2023, 9:32 am

Harpoon therapeutics announces updated interim tolerability and response data from phase 1/2 clinical trial of t cell engager hpn328 at esmo congress 2023

Confirmed response rate 35% (11/31), across all tumor types and patient cohorts treated with 1 mg primi...

October 21, 2023, 3:31 pm

Younger age, female gender linked to incident hyperthyroidism among af patients

Researchers conducted a cross-sectional cohort study to identify risk factors associated with incident ...

October 16, 2023, 6:14 pm

Black diamond therapeutics presents dose escalation data demonstrating durable responses in patients with nsclc from phase 1 trial of bdtx-1535

Initial results from BDTX-1535 dose escalation show durable activity in patients with NSCLC across heterogeneous EGFR mutation subtypes No new safety ...

October 14, 2023, 4:30 pm

Boa says that "the equal weighted s&p could rip" - could do double the s&p 500 gain

BofA Securities head of US equity and quantitative strategy in a Bloomberg TV interview overnight:probably a lot of this good news has been priced ......

October 12, 2023, 12:27 am

Polestar rocked as ev maker files for $1bn equity raise

Polestar Automotive (NASDAQ:PSNY) saw its stock down more than 9% in premarket, as investors reacted to a new $1 billion fundraise. The Sweden-based E...

October 11, 2023, 8:07 am

Oxford cannabinoid readies for next stage as it safely navigates phase i stduy

Oxford Cannabinoid Technologies Holdings PLC (LSE:OCTP, OTC:OCTHF) hailed as a 'major milestone' the successful completion of dosing for all ...

October 10, 2023, 2:22 am

We need to look for hits to specific cohorts not just the consumer broadly: charles schwab's sonders

Hosted by Brian Sullivan, “Last Call” is a fast-paced, entertaining business show that explores the intersection of money, culture and policy. Tun...

October 2, 2023, 8:58 pm

Roivant announces positive initial imvt-1402 phase 1 sad and 300 mg subcutaneous mad results

IMVT-1402 subcutaneous (SC) doses achieved peak Immunoglobulin G (IgG) reductions that are similar to those previously observed with batoclimab No dec...

September 26, 2023, 10:00 am

Immunovant announces positive initial imvt-1402 phase 1 sad and 300 mg subcutaneous mad results

IMVT-1402 subcutaneous (SC) doses achieved peak Immunoglobulin G (IgG) reductions that are similar to those previously observed with batoclimab No dec...

September 26, 2023, 10:00 am

World education services announces 14 u.s. communities selected to join its skilled immigrant integration program

NEW YORK, Sept. 20, 2023 (GLOBE NEWSWIRE) — World Education Services (WES) today announced the 14 communities selected to join the sixth ...

September 20, 2023, 5:29 pm

Harpoon therapeutics announces first patients with small cell lung cancer dosed in hpn328 combination cohort

SOUTH SAN FRANCISCO, Calif., Sept. 15, 2023 (GLOBE NEWSWIRE) — Harpoon Therapeutics, Inc. (Nasdaq: HARP), a clinical-stage immuno-oncology company d...

September 15, 2023, 11:15 am

Harpoon therapeutics abstract for hpn217 accepted for poster presentation at the 20th international myeloma society annual meeting

SOUTH SAN FRANCISCO, Calif., Sept. 06, 2023 (GLOBE NEWSWIRE) — Harpoon Therapeutics, Inc. (Nasdaq: HARP), a clinical-stage immuno-oncology company d...

September 6, 2023, 11:30 am

Have excess pandemic savings run out?

JPMorgan last week made the call that US pandemic savings have finally run out."Excess savings for US households when adjusting for inflation are now ...

August 29, 2023, 7:16 pm

3 energy stocks due for a massive short squeeze

Energy stocks have been undergoing a major transformation in the past year and a half, driven by a tripartite ...

August 29, 2023, 5:30 am


Search within

Pages Search Results: